四环生物(000518) - 2017 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was CNY 89,067,262.85, an increase of 1.38% year-on-year, and CNY 286,376,417.96 for the year-to-date, up 30.24%[8] - Net profit attributable to shareholders was CNY 14,526,888.11, down 4.94% year-on-year, while year-to-date net profit reached CNY 33,619,823.77, a significant increase of 224.27%[8] - Basic earnings per share for the reporting period were CNY 0.0141, a decrease of 4.73% year-on-year, while year-to-date basic earnings per share were CNY 0.0327, up 223.76%[8] - The company reported non-recurring gains and losses totaling CNY 25,133,034.84 for the year-to-date[9] Assets and Liabilities - Total assets at the end of the reporting period were CNY 945,937,438.48, a decrease of 7.02% compared to the end of the previous year[8] - The net assets attributable to shareholders increased to CNY 654,968,674.16, a rise of 7.18% compared to the previous year[8] - Cash and cash equivalents decreased by 41.24% from CNY 64,949,874.50 to CNY 38,162,381.36 due to profit distribution payments and increased promotional expenses[16] - Other payables increased by 1013.98% from CNY 12,367,438.42 to CNY 137,771,144.51, reflecting debts owed to original shareholders[16] - Fixed assets decreased by 70.56% from CNY 238,815,341.30 to CNY 70,317,171.56 due to a reduction in the consolidation scope[16] - Intangible assets decreased by 47.08% from CNY 69,344,195.55 to CNY 36,694,537.85, also due to a reduction in the consolidation scope[16] Cash Flow - The net cash flow from operating activities for the year-to-date was CNY -324,440,014.61, reflecting a decrease of 1,460.92%[8] - Operating cash flow turned negative at CNY -324,440,014.61, a decrease of 1460.92% compared to CNY 23,839,730.31 from the previous period[16] - Investment cash flow increased significantly by 4486.05% from CNY 5,589,417.99 to CNY 256,333,662.45 due to the disposal of 100% equity in Jiangsu Sihuan Biopharmaceutical Co., Ltd.[16] Shareholder Information - The total number of shareholders at the end of the reporting period was 72,373[12] - The largest shareholder, Wang Hongming, held 10.00% of the shares, amounting to 102,953,443 shares[12] Expenses - Sales expenses surged by 139.06% from CNY 44,371,805.13 to CNY 106,073,064.55 due to the impact of the two-invoice system[16] Other Information - The weighted average return on net assets was 1.68%, showing a slight decrease of 0.01% year-on-year[8] - The company did not engage in any securities or derivative investments during the reporting period[19][20] - Prepayments increased by 104.02% from CNY 7,417,265.78 to CNY 15,133,013.06 for equipment payments[16]